-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Ping An Healthcare and Technology (HKG:1833) Is In A Good Position To Deliver On Growth Plans
Ping An Healthcare and Technology (HKG:1833) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.
So should Ping An Healthcare and Technology (HKG:1833) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.
See our latest analysis for Ping An Healthcare and Technology
Does Ping An Healthcare and Technology Have A Long Cash Runway?
You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. When Ping An Healthcare and Technology last reported its balance sheet in June 2022, it had zero debt and cash worth CN¥10b. Importantly, its cash burn was CN¥1.2b over the trailing twelve months. Therefore, from June 2022 it had 8.5 years of cash runway. Importantly, though, analysts think that Ping An Healthcare and Technology will reach cashflow breakeven before then. In that case, it may never reach the end of its cash runway. The image below shows how its cash balance has been changing over the last few years.
SEHK:1833 Debt to Equity History September 22nd 2022How Well Is Ping An Healthcare and Technology Growing?
Some investors might find it troubling that Ping An Healthcare and Technology is actually increasing its cash burn, which is up 8.2% in the last year. Also concerning, operating revenue was actually down by 20% in that time. Considering both these metrics, we're a little concerned about how the company is developing. While the past is always worth studying, it is the future that matters most of all. So you might want to take a peek at how much the company is expected to grow in the next few years.
How Hard Would It Be For Ping An Healthcare and Technology To Raise More Cash For Growth?
Even though it seems like Ping An Healthcare and Technology is developing its business nicely, we still like to consider how easily it could raise more money to accelerate growth. Companies can raise capital through either debt or equity. Commonly, a business will sell new shares in itself to raise cash and drive growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations.
Since it has a market capitalisation of CN¥18b, Ping An Healthcare and Technology's CN¥1.2b in cash burn equates to about 6.9% of its market value. Given that is a rather small percentage, it would probably be really easy for the company to fund another year's growth by issuing some new shares to investors, or even by taking out a loan.
How Risky Is Ping An Healthcare and Technology's Cash Burn Situation?
As you can probably tell by now, we're not too worried about Ping An Healthcare and Technology's cash burn. In particular, we think its cash runway stands out as evidence that the company is well on top of its spending. While its falling revenue wasn't great, the other factors mentioned in this article more than make up for weakness on that measure. Shareholders can take heart from the fact that analysts are forecasting it will reach breakeven. Based on the factors mentioned in this article, we think its cash burn situation warrants some attention from shareholders, but we don't think they should be worried. Taking an in-depth view of risks, we've identified 1 warning sign for Ping An Healthcare and Technology that you should be aware of before investing.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts)
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
僅僅因為一家企業沒有賺到錢,並不意味着股票會下跌。例如,生物技術和採礦勘探公司經常虧損多年,然後才在新的治療方法或礦物發現方面取得成功。儘管如此,只有傻瓜才會忽視這樣一個風險,即一家虧損的公司太快地燒掉了現金。
所以也應該這樣平安好醫生(HKG:1833)股東擔心其燒錢嗎?就本文而言,現金消耗是指一家不盈利的公司為其增長提供資金而花費現金的年度比率;其負的自由現金流。我們將首先將其現金消耗與其現金儲備進行比較,以計算其現金跑道。
參見我們對平安好醫生的最新分析
平安好醫生有很長的現金跑道嗎?
你可以通過將公司擁有的現金數量除以它花掉這些現金的速度來計算公司的現金跑道。平安好醫生上一次報告資產負債表是在2022年6月,當時它沒有債務和現金,價值100億元人民幣。重要的是,在接下來的12個月裏,它的現金消耗為人民幣12億元。因此,從2022年6月開始,它有8.5年的現金跑道。不過,重要的是,分析人士認為,平安好醫生將在那之前實現現金流盈虧平衡。在這種情況下,它可能永遠不會走到現金跑道的盡頭。下圖顯示了其現金餘額在過去幾年中的變化情況。
聯交所:1833債轉股歷史2022年9月22日平安好醫生長得有多好?
一些投資者可能會覺得麻煩的是,平安好醫生實際上是增加它的現金消耗,去年上漲了8.2%。同樣值得關注的是,這段時間的營業收入實際上下降了20%。考慮到這兩個指標,我們有點擔心公司是如何發展的。雖然過去總是值得研究的,但最重要的是未來。因此,你可能想看看該公司在未來幾年的預期增長速度。
對於平安好醫生來説,籌集更多現金來實現增長有多難?
儘管平安好醫生的業務看起來發展得很好,但我們仍然願意考慮它籌集更多資金以加速增長的容易程度。公司可以通過債務或股權籌集資金。通常情況下,企業會自行發售新股,以籌集現金並推動增長。我們可以將一家公司的現金消耗與其市值進行比較,以瞭解一家公司需要發行多少新股才能為一年的運營提供資金。
由於其市值為180億元人民幣,平安好醫生的12億元現金消耗相當於其市值的6.9%左右。鑑於這只是一個相當小的比例,該公司很可能真的很容易通過向投資者發行一些新股,甚至通過貸款來為下一年的增長提供資金。
平安好醫生燒錢的風險有多大?
正如你現在可能已經知道的,我們並不太擔心平安好醫生的燒錢行為。特別是,我們認為它的現金跑道脱穎而出,證明該公司很好地控制了支出。雖然它的收入下降不是很大,但本文提到的其他因素足以彌補這一指標的疲軟。分析師預測股價將達到盈虧平衡,這讓股東們感到振奮。基於本文提到的因素,我們認為其現金消耗情況值得股東關注,但我們認為他們不必擔心。深入分析風險,我們發現平安好醫生的1個警示標誌在投資之前你應該意識到這一點。
當然了,如果你把目光投向別處,你可能會發現這是一筆很棒的投資。所以讓我們來看看這個免費感興趣的公司名單,以及這份名單中的成長股(根據分析師預測)
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧